Use access key #2 to skip to page content.
$0.38 -0.02 (-5.68%)
10/13/2008 9:41 AM

Panacos Pharmaceuticals, Inc. (PANC)

CAPS Rating:
****

A development stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other major human viral diseases.

View All Commentary (PANC)

Recs

0

Avatar steelpoker (< 20) Submitted: 11/08/07 2:30 AM : Outperform Start Price: $2.45 PANC Score: -48.74

Going up up up and away....

Report this Post Replies: 0 | Reply

Featured Broker Partners